(S)-Veliflapon

Modify Date: 2024-04-03 10:17:58

(S)-Veliflapon Structure
(S)-Veliflapon structure
Common Name (S)-Veliflapon
CAS Number 128253-32-7 Molecular Weight 361.43
Density N/A Boiling Point N/A
Molecular Formula C23H23NO3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of (S)-Veliflapon


(S)-Veliflapon ((S)-BAY X 1005; (S)-DG-031) is an orally active inhibitor of leukotriene biosynthesis and 5-lipoxygenase activating protein (FLAP). (S)-Veliflapon inhibits the formation of leukotriene B4 (LTB4) in rat, mouse and human leukocytes with IC50 values of 0.026 µM, 0.039 µM and 0.22 µM respectively. (S)-Veliflapon showes enantioselectivity in human whole blood[1][2][3].

 Names

Name (S)-Veliflapon

 (S)-Veliflapon Biological Activity

Description (S)-Veliflapon ((S)-BAY X 1005; (S)-DG-031) is an orally active inhibitor of leukotriene biosynthesis and 5-lipoxygenase activating protein (FLAP). (S)-Veliflapon inhibits the formation of leukotriene B4 (LTB4) in rat, mouse and human leukocytes with IC50 values of 0.026 µM, 0.039 µM and 0.22 µM respectively. (S)-Veliflapon showes enantioselectivity in human whole blood[1][2][3].
Related Catalog
In Vitro (S)-Veliflapon 以剂量依赖性方式减少了人全血中白三烯 B4 (LTB4) 的合成[1]。
References

[1]. Fruchtmann R, et al. In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis. Agents Actions. 1993 Mar;38(3-4):188-95.  

[2]. Hermann, David J., et al. Dosing schedules of leukotriene synthesis inhibitors for human therapy. World Intellectual Property Organization. WO2009002746.

[3]. Helgadottir, et al. Polymorphisms in the susceptibility genes for myocardial infarction, stroke, and peripheral artery occlusive disease and their use in risk assessment and prophylaxis therapy. United States. US20070280917.

 Chemical & Physical Properties

Molecular Formula C23H23NO3
Molecular Weight 361.43
Top Suppliers:I want be here

Get all suppliers and price by the below link:

(S)-Veliflapon suppliers

(S)-Veliflapon price

Related Compounds: More...
(S)-1-(4-bromophenylsulfonyl)pyrrolidin-3-ol
1001334-19-5
(S)-2-Amino-3-(2,4,6-trimethyl-phenyl)-propionic acid methyl ester
1213452-83-5
(S)-1-(p-tolyl)ethyl 2,3,4,5,6-pentafluorobenzoate
622852-35-1
(S)-Roche ester
80657-57-4
(S)-(-)-1,1-DIPHENYL-1,2-PROPANEDIOL
233772-38-8
(S)-2,4-dimethyl-docos-2t-enoic acid methyl ester
19789-09-4
(S)-N-(2,4-difluorobenzyl)-2'-ethyl-9'-hydroxy-1',8'-dioxo-1',2,2',4,4',5,6,8'-octahydrospiro[pyran-3,3'-pyrido[1,2-a]pyrazine]-7'-carboxamide
1799952-48-9
S-ethenyl N,N-dipropylcarbamothioate
101622-02-0
(S)-benzyl (1-((3-chloro-2-oxopropyl)amino)-1-oxopropan-2-yl)carbamate
90302-91-3
tert-Butyl 4-(((1-(2-chlorobenzyl)-1H-benzo[d]imidazol-2-yl)oxy)methyl)piperidine-1-carboxylate
1420860-13-4
tert-Butyl 3-(((1-(2-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)oxy)methyl)pyrrolidine-1-carboxylate
1420840-66-9
tert-Butyl 4-(((1-(2-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)oxy)methyl)piperidine-1-carboxylate
1420840-58-9
tert-Butyl 4-((benzo[d]oxazol-2-yloxy)methyl)piperidine-1-carboxylate
1420895-21-1
tert-Butyl 3-((benzo[d]thiazol-2-yloxy)methyl)pyrrolidine-1-carboxylate
1420992-38-6
tert-Butyl 4-((benzo[d]thiazol-2-yloxy)methyl)piperidine-1-carboxylate
1420980-27-3
tert-Butyl 4-((2-(furan-2-yl)-2-oxoethoxy)methyl)piperidine-1-carboxylate
1420804-46-1
tert-Butyl 4-((2-oxo-2-(pyrazin-2-yl)ethoxy)methyl)piperidine-1-carboxylate
1420877-03-7
tert-Butyl 3-(((2-bromopyridin-4-yl)methoxy)methyl)pyrrolidine-1-carboxylate
1420809-16-0
tert-Butyl 3-((pyridin-3-ylmethoxy)methyl)pyrrolidine-1-carboxylate
1420806-01-4